YOLFTbeta
Scienture Holdings, Inc.

Scienture Holdings, Inc.

SCNX · NASDAQ · Healthcare / Pharmaceutical Retailers

2.90USD-0.11 (-3.65%)

Price History

Full chart

Market Stats

Previous Close3.01
Open2.90
Day Range2.83 – 2.94
52-Week Range0.238 – 2.60
Volume4.42K
Market Cap11.07M
P/E (TTM)0.00
Forward P/E21.83
EPS-1.97
Dividend Yield0.00%
Beta3.98
50-Day Avg0.3783
200-Day Avg0.4146

About

Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States. The company develops SCN-102, an oral liquid formulation of losartan potassium that is in phase 1 for the treatment of hypertension, diabetic nephropathy, and reduction of the risk of stroke in patients with hypertension and left ventricular hypertrophy; and SCN-104, a multi-dose dihydroergotamine mesylate (DHE) injection pen. It also develops SCN-106, which is a thrombolytic agent that binds to fibrin in clots and converts entrapped plasminogen to plasmin; and SCN-107, a long-acting injection suspension formulation of a non-opioid analgesic for postsurgical local and regional analgesia. Scienture Holdings, Inc. is headquartered in Commack, New York.

Company Details

  • SectorHealthcare
  • IndustryPharmaceutical Retailers
  • CEODr. Shankar Hariharan Ph.D.
  • Employees4
  • Headquarters20 Austin Boulevard, Commack, NY, United States, 11725, USA
  • Websitehttps://scienture.com

Leadership

  • Dr. Shankar Hariharan Ph.D.Founder, Co-CEO & Executive Chairman · b. 1957
  • Dr. Narasimhan Mani M.B.A., Ph.D.President, Co-CEO, Interim CFO & Director · b. 1975
  • Mr. Rahul Surana M.B.A., Ph.D.Executive VP & COO of Scienture LLC
  • Ms. Michele RathSenior VP & Chief Commercial Officer of Scienture LLC

Financials

Income Statement

Currency: USD2005-12-312006-12-312007-12-312008-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue-----806.05K955.88K1.50M2.91M2.48M2.93M3.83M7.44M17.12M9.89M10.25M1.36M136.64K431.61K
Growth (%)------+18.59%+56.53%+94.66%-14.79%+18.11%+30.72%+94.07%+130.26%-42.24%+3.65%-86.69%-89.98%+215.87%
Cost of Revenue----6.28K689.81K944.07K440.05K189.84K16.36K-449.05K2.57M11.42M5.14M4.73M1.31M130.64K100.13K
Gross Profit-----6.28K116.24K11.81K1.06M2.72M2.47M2.93M3.38M4.87M5.71M4.75M5.52M49.03K6.00K331.48K
Gross Margin-----14.42%1.24%70.59%93.48%99.34%100.00%88.28%65.50%33.33%47.99%53.85%3.60%4.39%76.80%
Operating Expense----177.67K266.95K2.10M2.49M2.86M3.47M2.54M3.47M4.75M8.21M10.04M8.44M4.45M14.71M16.58M
Operating Income-702-8.72K-28.19K-28.50M-183.95K-150.71K-2.08M-1.43M-137.07K-1.01M395.10K-87.62K125.22K-2.51M-5.29M-2.92M-4.40M-14.70M-16.24M
Operating Margin------18.70%-218.02%-95.67%-4.71%-40.59%13.48%-2.29%1.68%-14.64%-53.51%-28.45%-322.36%-10758.70%-3763.78%
EBITDA-702-8.72K-28.19K-28.50M-181.32K-148.09K-2.08M-2.00M-133.27K-1.02M446.04K66.58K-136.47K-2.40M-5.15M-1.87M-6.29M-17.39M-38.93M
EBITDA Margin------18.37%-217.60%-133.88%-4.58%-41.16%15.22%1.74%-1.84%-14.04%-52.11%-18.27%-461.19%-12726.51%-9020.24%
Net Income-702-8.72K-28.19K-28.50M-183.95K-150.71K-2.09M-2.01M-1.12M-2.76M288.98K9.04K-284.43K-2.54M-5.32M-3.47M-17.84M9.07M-41.51M
Net Income Margin------18.70%-218.78%-134.47%-38.36%-111.21%9.86%0.24%-3.82%-14.81%-53.75%-33.87%-1308.34%6634.66%-9618.03%
R&D-3.56K--------863.32K949.95K-662.73K899.71K993.18K100.28K2.24M1.96M
R&D as % of Total Revenue----------29.45%24.79%-3.87%9.10%9.69%7.35%1636.89%453.25%
Interest Expense------7.28K4.15K119.51K151.50K157.06K57.54K53.23K29.39K23.59K336.21K1.14M1.34M4.08M
Interest Expense % of Total Revenue------0.76%0.28%4.10%6.10%5.36%1.50%0.72%0.17%0.24%3.28%83.82%977.46%946.04%

Balance Sheet

Currency: USD2005-12-312006-12-312007-12-312008-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets-13.17K1.77K687.00K9.19K118.68K403.87K1.22M2.03M337.12K617.48K2.23M5.57M9.79M5.77M3.71M12.53M104.85M84.18M
Total Liabilities-3.50K20.28K48.70M11.53K101.19K273.00K553.68K1.76M1.49M929.41K1.38M1.43M1.11M2.00M3.37M11.99M25.78M14.06M
Total Equity-9.67K-18.51K-48.01M-2.34K17.48K130.87K668.44K267.02K-1.15M-311.93K844.67K4.14M8.68M3.77M763.14K542.35K79.07M70.12M
Cash-13.17K1.77K687.00K4.96K3.38K84.32K705.60K78.71K14.68K183.91K869.56K2.87M5.92M3.12M1.09M314308.10K6.66M
Total Debt---19.33M9.00K12.80K19.33K-1.11M781.35K666.36K844.05K997.81K627.46K1.25M1.58M6.76M3.53M24.14K
Net Debt--13.17K-1.77K18.65M4.04K9.42K-64.98K-705.60K1.03M766.67K482.45K-25.50K-1.87M-5.29M-1.87M489.01K6.76M3.22M-6.64M

Cash Flow

Currency: USD2006-12-312007-12-312008-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-6.22K-16.07K-28.16K-181.89K-163.12K-844.58K-1.06M-1.97M-1.31M171.67K273.39K141.78K-2.21M-2.57M-1.56M-2.23M-14.27M-13.38M
Investing Cash Flow----1.21K--10.99K---78.00K--265.28K-332.25K-37.51K-22.60K-427.85K-275.72K27.55M-
Financing Cash Flow16.60K4.67K27.08K186.38K161.53K936.51K1.69M1.36M1.17M-2.44K677.54K2.19M5.30M-208.18K-35.17K1.41M-12.98M19.73M
Capital Expenditure0001.21K010.99K000015.01K82.25K37.51K22.60K450.85K212.00K3
Free Cash Flow-6.22K-16.07K-28.16K-183.10K-163.12K-855.57K-1.06M-1.97M-1.31M171.67K258.38K59.52K-2.25M-2.59M-1.56M-2.23M-14.28M-13.38M
Dividends Paid---------------014.86M0
FCF to OCF100.00%100.00%100.00%100.66%100.00%101.30%100.00%100.00%100.00%100.00%94.51%41.98%101.69%100.88%100.00%100.00%100.08%100.00%
Dividend Paid to FCF---------------0.00%-104.07%0.00%

Earnings

Report DateMar 31, 2009Jun 30, 2009Sep 30, 2009Mar 31, 2013May 28, 2014Sep 3, 2014Dec 3, 2014Feb 25, 2015May 6, 2015Sep 2, 2015Nov 2, 2015Mar 29, 2016Apr 21, 2016Aug 8, 2016Nov 14, 2016Mar 28, 2017May 10, 2017Aug 7, 2017Nov 13, 2017Mar 27, 2018May 9, 2018Aug 9, 2018Oct 26, 2018Mar 26, 2019May 8, 2019Jul 29, 2019Oct 31, 2019Mar 25, 2020May 4, 2020Jul 27, 2020Oct 26, 2020Mar 29, 2021Apr 26, 2021Jul 26, 2021Oct 25, 2021Mar 28, 2022May 9, 2022Jul 25, 2022Nov 7, 2022Mar 27, 2023May 15, 2023Jul 24, 2023Oct 25, 2023Mar 25, 2024Apr 24, 2024Jul 22, 2024Nov 29, 2024Mar 26, 2025Apr 21, 2025Aug 12, 2025Nov 12, 2025Mar 30, 2026May 15, 2026Aug 13, 2026Nov 11, 2026
EPS Estimate---------------0.00--------0.020.010.010.060.010.010.030.01-0.06-0.09-0.12-0.14-0.10-0.06-0.12-0.27-0.02-0.45-----0.38--0.00-0.28-0.22-0.09-
EPS Actual-10.28-2.25-3.92-687.62-2.85-0.92-1.07-1.26-1.28-0.16-0.36-1.43-1.07-3.15-2.700.000.21-0.020.200.390.220.050.24-0.010.310.140.07-1.200.30-1.050.30-4.35-1.20-4.80-2.40-1.50-1.80-1.95-0.90-1.50-0.07-2.90-4.57-12.9520.49-1.30-1.34-0.79-0.33-0.48-0.19-0.13-0.08-0.07-
Surprise------------------------1466.00%1335.00%584.00%-2100.00%2900.00%-10600.00%900.00%-43600.00%-2016.40%-5436.33%-1900.00%-971.43%-1761.43%-3445.45%-682.61%-448.85%-250.00%-544.24%------307.89%---53.57%63.64%22.22%-
Timing------------------------------------------------After-hours--Pre-marketAfter-hoursAfter-hours-

Key Statistics & Ratios

Market Cap11.07M
Enterprise Value14.40M
Trailing P/E0.00
Forward P/E21.83
Price / Sales13.48
Price / Book0.19
EPS-1.97
Book Value1.56
Revenue (TTM)821.32K
Gross Profit (TTM)720.44K
EBITDA-12.36M
Profit Margin0.00%
Operating Margin-785.63%
Return on Equity-53.47%
Return on Assets-8.93%
Shares Outstanding41.06M
Shares Float32.00M
Beta3.98
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Ownership Breakdown

Institutions
5.30%
Insiders
25.86%
Retail / Other
68.84%

Top Institutional Holders

  • Geode Capital Management, LLC
    432.19K1.05%
  • Vanguard Capital Management, LLC
    408.09K0.99%
  • Vanguard Fiduciary Trust Co
    198.06K0.48%
  • Citadel Advisors Llc
    164.85K0.40%
  • UBS Group AG
    107.83K0.26%
  • Virtu Financial LLC
    84.21K0.21%
  • XTX Topco Ltd
    47.68K0.12%
  • TWO SIGMA SECURITIES, LLC
    36.45K0.09%
  • Jane Street Group LLC
    27.64K0.07%
  • Private Advisor Group, LLC
    15.00K0.04%
  • Northern Trust Corp
    13.89K0.03%
  • Citigroup Inc
    5.55K0.01%
  • SBI Securities Co Ltd
    550.00%
  • Nova Wealth Management, Inc.
    300.00%
  • Tower Research Capital LLC
    00.00%
  • Commonwealth Equity Services, LLC
    00.00%

Top Fund Holders

  • Fidelity Extended Market Index
    166.04K0.40%
  • Vanguard MStar Total Stk Mkt Idx Invest
    102.30K0.25%
  • Fidelity Total Market Index
    53.47K0.13%
  • Fidelity Series Total Market Index
    45.35K0.11%

Dividends

20242×
1.50Jul 19, 20248.00Mar 25, 2024

Stock Splits

  • Jun 22, 20231:15